Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Astra Zeneca
1 vial
Durvalumab
Keep in cold place
Delivering To:
Overview
Imfinzi 500mg Injection is a prescription-based anticancer medicine. It is used to treat various cancers, including Non-small cell lung cancer, Liver cancer, Endometrial Cancer, and Biliary Tract Cancer. This medication works by blocking the activity of programmed death-ligand 1 (PD-L1) proteins and helps the immune system attack cancer cells. This medicine is administered through intravenous injection by your doctor or nurse.
Non-small cell lung cancer
Like most anticancer drugs, Imfinzi 500mg Injection may cause some adverse effects on the body during the treatment. These can vary from mild to severe depending on the dose and the patient’s health condition.
Common side effects include:
Chest pain
Stuffy nose
Muscle pain
Cough
Weakness
Nausea
Rash
Painful urination
Vomiting
Decreased appetite
Swelling in your arms and legs
Weight loss
Shortness of breath
Feeling tired
Blurred vision
Sore throat
Inform your doctor immediately if you experience any persistent or unusual side effects.
Imfinzi 500mg Injection should be given intravenously by a doctor or experienced nurse under strict medical supervision. It is not intended for self-administration. The doctor will determine the appropriate dosage and duration of treatment based on the type and stage of cancer, as well as the patient's health condition. It can be used alone or in combination with other medicines during the treatment.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Imfinzi 500mg Injection, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take Imfinzi 500mg Injection without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Imfinzi 500mg Injection is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
mfinzi 500mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Imfinzi 500mg Injection is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Liver
caution
Imfinzi 500mg Injection is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
In case you missed a dose of Durvalumab injection, immediately contact your doctor. It is important to take the dose of this medicine as scheduled.
This medicine is used to treat various cancers, including Non-small cell lung cancer, Liver cancer, Endometrial cancer, and Biliary Tract Cancer.
Imfinzi 500mg Injection is an immunotherapy that works by helping your immune system to fight cancer. This medicine blocks the action of PD-L1, exerts its anticancer effects by increasing T-cell activation, and allows them to destroy cancer cells.
This medicine is administered by a doctor or a nurse. It is injected slowly into your vein. This infusion usually lasts 60 minutes, and this medicine is given once every 2 to 4 weeks.
Some common side effects include nausea, mouth soreness, chest pain, muscle pain, weakness, weight loss, vomiting, shortness of breath, blurred vision, infection, rashes, fever, etc.
This medicine may cause dizziness, which affects your ability to drive and concentrate.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Dewi, I. G. A. G. S., Putri, L. A. L. N., Silalahi, L. D., Widha, I. G. A., Dewi, P., Hapsari, M. D., ... & Warditiani, N. K. (2025). Systematic Literature Review on Sterile Injectable Dates of Use, Stability and Implications for Use. Svāsthya: Trends in General Medicine and Public Health, 2(1), e66-e66.
2. Paik, P. K., Luo, J., Ai, N., Kim, R., Ahn, L., Biswas, A., ... & Kris, M. G. (2022). Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature Communications, 13(1), 6095.
3. Al-Salama, Z. T. (2021). Durvalumab: a review in extensive-stage SCLC. Targeted Oncology, 16(6), 857-864.
4. Almasi, J., Thiesen, J., & Krämer, I. (2023). Physicochemical stability of durvalumab (Imfinzi®) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy, 8(1), 20230008.
5. Day-Storms, J. (2023). IMJUDO (Tremelimumab-actl) in Combination With IMFINZI (Durvalumab) Receives FDA Approval for HCC and NSCLC.
6. Rashid, M. A. (2023). New Indications & Dosage Forms for Existing Drugs Vol. 26 (1). Bangladesh Pharmaceutical Journal, 26(1), 114-118.
Astra Zeneca
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.